Anti-FSTL1/FRP抗体(ab11805)
Key features and details
- Goat polyclonal to FSTL1/FRP
- Suitable for: WB
- Reacts with: Human
- Isotype: IgG
选择批间可重复性更高的重组抗体
- 研究可靠 —— 各批次间结果一致且可重复
- 长期批量供应 —— 采用重组技术,可实现快速生产
- 首次实验即可成功 —— 经过大量验证确认了特异性
- 符合伦理标准 —— 产品不含动物成分
概述
-
产品名称
Anti-FSTL1/FRP抗体
参阅全部 FSTL1/FRP 一抗 -
描述
山羊多克隆抗体to FSTL1/FRP -
宿主
Goat -
经测试应用
适用于: WBmore details -
种属反应性
与反应: Human
预测可用于: Cow, Cynomolgus monkey -
免疫原
Synthetic peptide corresponding to Human FSTL1/FRP aa 296-308 (C terminal).
Sequence:C-TAEKTKRVSTKEI
(Peptide available asab23213) -
常规说明
The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.
If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
存储溶液
pH: 7.30
Preservative: 0.02% Sodium azide
Constituents: Tris buffered saline, 0.5% BSA -
Concentration information loading...
-
纯度
Immunogen affinity purified -
纯化说明
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. -
克隆
多克隆 -
同种型
IgG -
研究领域
相关产品
-
Compatible Secondaries
-
Isotype control
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab11805于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
WB | (1) |
Use a concentration of 0.3 - 1 µg/ml. Detects a band of approximately 50 kDa (predicted molecular weight: 35 kDa).
A 1 hour primary incubation is recommended for this product. The observed molecular weight corresponds to earlier findings in literature (Tanaka et al, Int Immunol. 1998 Sep;10(9):1305-14. |
说明 |
---|
WB
Use a concentration of 0.3 - 1 µg/ml. Detects a band of approximately 50 kDa (predicted molecular weight: 35 kDa). A 1 hour primary incubation is recommended for this product. The observed molecular weight corresponds to earlier findings in literature (Tanaka et al, Int Immunol. 1998 Sep;10(9):1305-14. |
靶标
-
功能
May modulate the action of some growth factors on cell proliferation and differentiation. Binds heparin. -
组织特异性
Overexpressed in synovial tissues from rheumatoid arthritis. -
序列相似性
Contains 2 EF-hand domains.
Contains 1 follistatin-like domain.
Contains 1 Kazal-like domain.
Contains 1 VWFC domain. -
细胞定位
Secreted. - Information by UniProt
-
数据库链接
- Entrez Gene: 534482 Cow
- Entrez Gene: 102131597 Cynomolgus monkey
- Entrez Gene: 11167 Human
- Omim: 605547 Human
- SwissProt: Q58D84 Cow
- SwissProt: Q9GKY0 Cynomolgus monkey
- SwissProt: Q12841 Human
- Unigene: 269512 Human
-
别名
- Anti FSTL1 antibody
- FLJ50214 antibody
- FLJ52277 antibody
see all
图片
-
Anti-FSTL1/FRP antibody (ab11805) at 0.5 µg/ml + Human Placenta lysate (RIPA buffer, 35µg total protein per lane)
Predicted band size: 35 kDa
Observed band size: 50 kDa why is the actual band size different from the predicted?
Primary incubated for 1 hour. Detected by western blot using chemiluminescence.
数据表及文件
-
SDS download
-
Datasheet download
文献 (11)
ab11805 被引用在 11 文献中.
- Inoue K et al. Aerobic exercise training-induced follistatin-like 1 secretion in the skeletal muscle is related to arterial stiffness via arterial NO production in obese rats. Physiol Rep 10:e15300 (2022). PubMed: 35585770
- Li L et al. A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis. Genome Biol 22:54 (2021). PubMed: 33514403
- Cao H et al. Inhibition of long non-coding RNA HOXA11-AS against neuroinflammation in Parkinson's disease model via targeting miR-124-3p mediated FSTL1/NF-?B axis. Aging (Albany NY) 13:11455-11469 (2021). PubMed: 33839699
- Sundaram GM et al. HuR enhances FSTL1 transcript stability to promote invasion and metastasis of squamous cell carcinoma. Am J Cancer Res 11:4981-4993 (2021). PubMed: 34765305
- Zhao Y et al. Follistatin-Like 1 Protects against Doxorubicin-Induced Cardiomyopathy through Upregulation of Nrf2. Oxid Med Cell Longev 2020:3598715 (2020). PubMed: 32831995